US Ambulatory Surgical Centers Market to Reach $53.67 Billion by 2029
The US Ambulatory Surgical Centers Market report unveils the strategic shifts in the US healthcare industry towards value-based care, spotlighting the pivotal role of Ambulatory Surgical Centers (ASCs) in this transformation. As the industry gravitates toward bundled payments, ASCs emerge as optimal settings for cost-efficient outpatient procedures, aligning perfectly with the objectives of value-based care models.
To know more,
https://www.focusreports.store/report/us-ambulatory-surgical-centersmarket-focused-insights
The US Ambulatory Surgical Centers (ASCs) market is experiencing substantial growth, with its valuation at $36.54 billion in 2023 and an expected rise to $53.67 billion by 2029, marking a CAGR of 6.62%. The market is expanding with approximately 6,000 functioning ASCs due to the healthcare industry's shift from hospital outpatient settings to more cost-effective ASCs.
Over 20% of hospital surgeries have transitioned to ASCs, spurred by the advantages of lower surgery costs and the shift toward value-based healthcare. Factors such as favorable reimbursement policies, same-day discharge, reduced costs, and skilled medical staff increasingly influence patients to opt for ASCs.
Highlights
• There are more than 6000 Medicare-certified ASCs in the US. The number of ASCs is increasing and will become the future of outpatient settings in the US. There is a major shift in the number of surgeries from hospitals to ASCs in various specialties.
• The ownership changes in the market are revolutionizing the number of ASCs. Hospitals are partnering with physicians to own the ASCs and refer patients to ASCs for surgeries. Corporations are partnering with the ASCs, helping them to invest in better technology, partnering with physicians, and more. This has increased the competition among the healthcare providers.
• From 2016 to 2022, more than 5% of gastroenterology surgeries shifted from hospitals to ASCs, as it is more affordable in ASCs than hospitals. The number of people suffering from gastroenterology disorders is increasing in the US and will increase further.
• In 2019, the number of ophthalmology ASCs in the US was less than 100; in 2022, it increased to more than 1,000. This segment is still growing at a faster rate in the market, and the number of ASCs is rising.
• The reimbursement schemes, awareness among the patients, and competition among the healthcare sectors are driving the ASCs market to the next level with rapid expansion in numbers.
• After the COVID-19 pandemic, some of the segments went online, and telehealth has impacted the market. The majority of people take consultations through telehealth platforms and get the surgery done in ASCs, eliminating the visits to hospitals in the US.
• The increasing aged population in the US, lifestyle changes, increasing disposable income, obesity, and chronic conditions are increasing the healthcare issues, in turn increasing the number of surgeries conducted
• ASCs are moving to become a single specialty as they are economical and can become more specialized in one particular field. This attracts patients with specialty-related issues to get the surgery in one particular center as they have more skilled and specialized technology to perform the surgeries.
Regional Analysis
One of the main drivers for the surge in surgeries conducted at ASCs is the growing patient volume, especially for standard procedures like cataract surgery. The South region of the US, with a large and growing population, is becoming an epicenter for ASC growth, particularly in states like Florida and Georgia.
This expansion is further fueled by the region's health profile, where a significant portion of the population suffers from conditions such as obesity and cardiovascular diseases. Florida, Georgia, North Carolina, and Mississippi are identified as prime locations for new ASC development, with substantial market potential for both corporate and physician-based ASCs.